Family History of Cancer and Cancer Risks in Women with BRCA1 or BRCA2 Mutations-Reference-Cited by-同舟云学术

Family History of Cancer and Cancer Risks in Women with BRCA1 or BRCA2 Mutations

Published:2010-11-23 Issue:24 Volume:102 Page:1874-1878
ISSN:0027-8874
Container-title:JNCI Journal of the National Cancer Institute
language:en
Short-container-title:JNCI Journal of the National Cancer Institute

Author:

Metcalfe K.,Lubinski J.,Lynch H. T.,Ghadirian P.,Foulkes W. D.,Kim-Sing C.,Neuhausen S.,Tung N.,Rosen B.,Gronwald J.,Ainsworth P.,Sweet K.,Eisen A.,Sun P.,Narod S. A.,

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/102/24/1874/7672101/djq443.pdf

Reference5 articles.

1. AGE AT ONSET AS AN INDICATOR OF FAMILIAL RISK OF BREAST CANCER

2. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease

3. Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies

4. Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population

5. BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification and validation of Golgi apparatus-related signature for predicting prognosis and immunotherapy response in breast cancer;Journal of Cancer Research and Clinical Oncology;2024-02-01

2. Exploring Citrus sinensis Phytochemicals as Potential Inhibitors for Breast Cancer Genes BRCA1 and BRCA2 Using Pharmacophore Modeling, Molecular Docking, MD Simulations, and DFT Analysis;ACS Omega;2024-01-03

3. BRCA1 frameshift variants leading to extended incorrect protein C termini;Human Genetics and Genomics Advances;2023-10

4. Identification and Validation of Golgi Apparatus-Related Signature for Predicting Prognosis and Immunotherapy Response in Breast Cancer;2023-09-06

5. Prevalence of Pathogenic Germline Variants in Women with Non-Familial Unilateral Triple-Negative Breast Cancer;Breast Care;2023